Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Interest & Investment Income (2019 - 2025)

Historic Interest & Investment Income for Eton Pharmaceuticals (ETON) over the last 4 years, with Q3 2025 value amounting to -$592000.0.

  • Eton Pharmaceuticals' Interest & Investment Income fell 730000.0% to -$592000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year decrease of 251960.78%. This contributed to the annual value of $281000.0 for FY2019, which is 7134.15% up from last year.
  • As of Q3 2025, Eton Pharmaceuticals' Interest & Investment Income stood at -$592000.0, which was down 730000.0% from -$1.0 million recorded in Q2 2025.
  • Eton Pharmaceuticals' Interest & Investment Income's 5-year high stood at -$8000.0 during Q3 2024, with a 5-year trough of -$1.0 million in Q2 2025.
  • Its 3-year average for Interest & Investment Income is -$335111.1, with a median of -$124000.0 in 2023.
  • In the last 5 years, Eton Pharmaceuticals' Interest & Investment Income surged by 9126.98% in 2024 and then plummeted by 924545.45% in 2025.
  • Over the past 3 years, Eton Pharmaceuticals' Interest & Investment Income (Quarter) stood at -$31000.0 in 2023, then surged by 74.19% to -$8000.0 in 2024, then plummeted by 7300.0% to -$592000.0 in 2025.
  • Its Interest & Investment Income was -$592000.0 in Q3 2025, compared to -$1.0 million in Q2 2025 and -$1.0 million in Q1 2025.